Agency Forms Undergoing Paperwork Reduction Act Review, 82899-82900 [2023-26081]

Download as PDF Federal Register / Vol. 88, No. 226 / Monday, November 27, 2023 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Board of Scientific Counselors Infectious Diseases; (Formerly Known as the Board of Scientific Counselors, Deputy Director for Infectious Diseases); Notice of Charter Renewal World Trade Center Health Program Scientific/Technical Advisory Committee; Amended Notice of Solicitation of Nominations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of charter renewal. SUMMARY: The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the renewal of the charter of the Board of Scientific Counselors Infectious Diseases (BSC ID); (formerly known as the Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID)). FOR FURTHER INFORMATION CONTACT: Sarah Wiley, M.P.H., Designated Federal Officer, Board of Scientific Counselors Infectious Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road NE, Mailstop H16–5, Atlanta, Georgia 30329–4027. Telephone: (404) 639–4840; Email: SWiley@cdc.gov. CDC is providing notice under 5 U.S.C. 1001– 1014 of the renewal of the charter of the Board of Scientific Counselors Infectious Diseases (formerly known as the Board of Scientific Counselors, Deputy Director for Infectious Diseases), Centers for Disease Control and Prevention, Department of Health and Human Services. This charter has been renewed for a two-year period through October 31, 2025. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. khammond on DSKJM1Z7X2PROD with NOTICES SUPPLEMENTARY INFORMATION: Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–26040 Filed 11–24–23; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:43 Nov 24, 2023 Jkt 262001 Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: SUMMARY: The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), is seeking nominations for membership on the World Trade Center (WTC) Health Program Scientific/Technical Advisory Committee (WTCHP–STAC), in accordance with provisions of the James Zadroga 9/11 Health and Compensation Act of 2010. The WTCHP–STAC consists of 17 members including experts in fields associated with occupational medicine, pulmonary medicine, environmental medicine, environmental health, industrial hygiene, epidemiology, toxicology, and mental health, and representatives of WTC responders as well as representatives of certified-eligible WTC survivors. SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the solicitation of nominations for appointment to the World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP–STAC). The solicitation of nominations notice was published in the Federal Register on October 6, 2023, 88 FR 69636–69637. The solicitation notice is being amended to extend the deadline for submission of nominations from November 20, 2023, in the original Federal Register notice, to December 30, 2023. The notice should read as follows: DATES: Nominations for membership on the STAC must be received no later than December 30, 2023. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to NIOSH Docket 229–K, c/o Ms. Mia Wallace, Committee Management Specialist, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–4, Atlanta, Georgia 30329–4027, or emailed to nioshdocket@cdc.gov. FOR FURTHER INFORMATION CONTACT: Tania Carreo´n-Valencia, Ph.D., M.S., PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 82899 Designated Federal Officer, World Trade Center Health Program Scientific/ Technical Advisory Committee, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop R–12, Atlanta, Georgia 30329–4027. Telephone: (513) 841–4515 (this is not a toll-free number); Email: TCarreonValencia@cdc.gov. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–26039 Filed 11–24–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–24–23GC] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled ‘‘NCEZID Rapid Message Testing & Development System’’ to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on June 16, 2023 to obtain comments from the public and affected agencies. CDC received one comment related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; E:\FR\FM\27NON1.SGM 27NON1 82900 Federal Register / Vol. 88, No. 226 / Monday, November 27, 2023 / Notices (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Rapid Message Testing & Development System—New—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) offers numerous powerful resources to anticipate, prevent, and address outbreaks of infectious diseases. From researchers to emergency responders; from laboratories to surveillance of mobile populations; from collaborations at the federal level to partnerships at the local level, NCEZID keeps people safe from threats like anthrax, Ebola virus, Zika virus, sepsis, mpox, and foodborne illnesses like Salmonella. These efforts are vital to protect and save lives. The ability to effectively communicate with the public about these threats is one of NCEZID’s most vital roles. Particularly during an outbreak, it is critical that the public understands what is happening and why, and trusts and follows public health leaders’ guidance. Recent public health responses to COVID–19 and mpox have underscored the need to improve the speed and content of health communications, particularly among populations at higher risk for zoonotic and infectious diseases. This Rapid Message Testing & Message Development System will enable NCEZID to collect information vital to the development of clear, salient, relevant, appealing, and persuasive messages related to outbreaks and other emerging and zoonotic diseases. The System will also allow for the relatively rapid testing of messages when the need arises within the Center, prior to the dissemination of those messages and associated communications materials. The data collection is intended to ensure NCEZID messages are clear, salient, appealing, and persuasive to target audiences. Data will guide revisions to existing or draft messages, inform the development of new messages, and otherwise enable message developers to make optimal decisions about message content, format, and dissemination so that NCEZID’s messages effectively reach and resonate with their intended audiences. Data collection methods proposed for this system include indepth interviews, online or in-person focus groups, and online surveys. CDC requests OMB approval for an estimated 3,431 annualized burden hours. There is no cost to respondents other than their time to participate. ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average burden per response (in hours) 10,000 720 1 1 10/60 5/60 Content question bank ................................. Screening question bank ............................. Content question bank ................................. Screening question bank ............................. 72 2,880 288 2,880 1 1 1 1 1 5/60 2 5/60 Content question bank ................................. 288 1 2 Number of respondents Type of respondents Form name Online surveys (general public) ....................................................... Online in-depth interview screening (healthcare and specialty audiences). Online in-depth interviews (healthcare and specialty audiences) ... Online focus group screening (general public) ................................ Online focus groups (general public) ............................................... Online focus group screening (healthcare and specialty audiences). Online focus groups (healthcare and specialty audiences) ............. Content question bank ................................. Screening question bank ............................. Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2023–26081 Filed 11–24–23; 8:45 am] khammond on DSKJM1Z7X2PROD with NOTICES BILLING CODE 4163–18–P VerDate Sep<11>2014 17:43 Nov 24, 2023 Jkt 262001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1

Agencies

[Federal Register Volume 88, Number 226 (Monday, November 27, 2023)]
[Notices]
[Pages 82899-82900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26081]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-23GC]

Agency Forms Undergoing Paperwork Reduction Act Review

In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``NCEZID Rapid Message Testing & Development
System'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on June 16,
2023 to obtain comments from the public and affected agencies. CDC
received one comment related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;

[[Page 82900]]

(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.

Proposed Project

Rapid Message Testing & Development System--New--National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).

Background and Brief Description

CDC's National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID) offers numerous powerful resources to anticipate, prevent, and
address outbreaks of infectious diseases. From researchers to emergency
responders; from laboratories to surveillance of mobile populations;
from collaborations at the federal level to partnerships at the local
level, NCEZID keeps people safe from threats like anthrax, Ebola virus,
Zika virus, sepsis, mpox, and foodborne illnesses like Salmonella.
These efforts are vital to protect and save lives. The ability to
effectively communicate with the public about these threats is one of
NCEZID's most vital roles. Particularly during an outbreak, it is
critical that the public understands what is happening and why, and
trusts and follows public health leaders' guidance. Recent public
health responses to COVID-19 and mpox have underscored the need to
improve the speed and content of health communications, particularly
among populations at higher risk for zoonotic and infectious diseases.
This Rapid Message Testing & Message Development System will enable
NCEZID to collect information vital to the development of clear,
salient, relevant, appealing, and persuasive messages related to
outbreaks and other emerging and zoonotic diseases. The System will
also allow for the relatively rapid testing of messages when the need
arises within the Center, prior to the dissemination of those messages
and associated communications materials. The data collection is
intended to ensure NCEZID messages are clear, salient, appealing, and
persuasive to target audiences. Data will guide revisions to existing
or draft messages, inform the development of new messages, and
otherwise enable message developers to make optimal decisions about
message content, format, and dissemination so that NCEZID's messages
effectively reach and resonate with their intended audiences. Data
collection methods proposed for this system include in-depth
interviews, online or in-person focus groups, and online surveys.
CDC requests OMB approval for an estimated 3,431 annualized burden
hours. There is no cost to respondents other than their time to
participate.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Online surveys (general public)...... Content question bank... 10,000 1 10/60
Online in-depth interview screening Screening question bank. 720 1 5/60
(healthcare and specialty audiences).
Online in-depth interviews Content question bank... 72 1 1
(healthcare and specialty audiences).
Online focus group screening (general Screening question bank. 2,880 1 5/60
public).
Online focus groups (general public). Content question bank... 288 1 2
Online focus group screening Screening question bank. 2,880 1 5/60
(healthcare and specialty audiences).
Online focus groups (healthcare and Content question bank... 288 1 2
specialty audiences).
----------------------------------------------------------------------------------------------------------------

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-26081 Filed 11-24-23; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.